Milestone Pharmaceuticals Inc.
MIST· Nasdaq
Released May 13, 2024, before the open
10-Q filed May 13, 2024, 43 days after period end · 0001558370-24-007860
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Net Income | -$10.35M | -$14.95M | -$14.01M | -$12.51M |
| EPS Diluted | -$0.21 | -$0.35 | -$0.33 | -$0.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Milestone Pharmaceuticals Inc. · CIK 1408443 · Engraved from SEC EDGAR